NIH-funded research R01 grant

Target PAQR4-Ceramide-GPNMB Pathway in MASH (liver disease)

Official title: Target PAQR4-Ceramide-GPNMB Pathway in MASH

Funded at University of Kentucky · NIH-11432577 · Data updated 2026-11-12

A patient-centered look at how a liver disease pathway involving PAQR4, ceramides, and GPNMB might lead to better biomarkers and therapies for MASLD and MASH.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky
NIH-funded
Lab location1 site (Lexington, United States)
Project startAugust 10, 2026
Project endApril 30, 2030
Funding year2026
Award (this year)$736,529
NIH project number1R01DK148764-01
Project IDNIH-11432577 on NIH RePORTER

Who could benefit from this research

Could help

People with MASLD/MASH or at risk for these conditions could benefit from the discoveries and potential future tests or treatments.

Less likely to help

Early-stage basic research findings may not yet translate to immediate patient benefits.

What this research studies

This grant focuses on understanding a liver disease called MASLD/MASH and how specific molecules in liver and fat tissue contribute to its progression. Researchers are studying PAQR4 and ceramide levels, plus the role of GPNMB, to uncover how these parts drive liver injury and fibrosis. The work includes analyzing human tissue data and experiments in cells and animal models to map how these pathways interact and worsen disease. The goal is to identify targets that could lead to noninvasive tests and new treatments for people with MASLD and MASH.

Why it matters

Potential benefit: If successful, this research could lead to better biomarkers and new therapies to prevent liver damage in people with MASLD/MASH.

How similar studies have gone: Previous work shows PAQR4-ceramide links influence liver metabolism and fibrosis, supporting potential relevance to humans.

Where this research is happening

  • University of Kentucky
    Lexington, United States
    Active

Researchers

  • Principal investigator: Zhu, Qingzhang — University of Kentucky
  • Study coordinator: Zhu, Qingzhang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.